Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms

NCT01007253 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Chicago

Collaborators